Skip to main content
. 2018 Jun 25;15(2):86–94. doi: 10.5114/kitp.2018.76473

Table IV.

Model of vasoactive-inotropic score value. Model type: binomial

Variable P-value Odds ratio 95% CI
Intercept 0.0033 0.2435 0.0932 0.6149
Cardioplegia: FR 0.0416 1.5198 1.0165 2.2765
Cardioplegia: ST 0.0140 1.6503 1.1078 2.4648
Age: 90–319 days 0.0537 0.5785 0.3300 1.0058
Age: 319–860 days 0.6587 0.8406 0.3900 1.8262
Age: 860–999 days 0.5105 1.4862 0.4652 4.9541
CHD type: ASDII 0.4268 0.7333 0.3431 1.5910
CHD type: AVSD 0.3386 1.4717 0.6686 3.2680
CHD type: AVVI 0.0495 2.3700 1.0090 5.6761
CHD type: MIX 0.1619 1.7387 0.8051 3.8086
CHD type: TGA 0.8591 1.0910 0.4207 2.8950
CHD type: ToF < 0.0001 6.0350 2.6233 14.3336
CHD type: UVH 0.2662 1.6706 0.6804 4.1770
CHD type: VSD 0.6426 0.8423 0.4094 1.7523
BSA: 0.25–0.38 m2 0.8534 0.9514 0.5616 1.6192
BSA: 0.38–0.54 m2 0.0041 0.3245 0.1493 0.6951
BSA: 0.54–0.59 m2 0.0002 0.0986 0.0287 0.3228
Genetic 0.1002 1.5265 0.9235 2.5360
Redo surgery 0.0320 1.7736 1.0564 3.0173
CBP time: 54–86 min < 0.0001 4.6875 2.6491 8.5421
CBP time: 86–110 min < 0.0001 7.1750 3.9919 13.2737
CBP time: 110–126 min < 0.0001 13.0896 6.9434 25.4268

Cross-validation estimate of prediction error: preliminary model: 0.179, the best model: 0.157.

CHD – type of congenital cardiac disease, CBP time – cardiopulmonary bypass time, FR – Fresenius crystalloid cardioplegic solution, ST – St. Thomas crystalloid cardioplegic solution, BSA – patient’s body surface area, ASD II – atrial septal defect, AVSD – atrioventricular septal defect, AVVI – isolated atrioventricular valve malformations, MIX – other, less frequent cardiac malformations, TGA – all spectrum of transposition of great arteries, ToF – tetralogy of Fallot, UVH – all spectrum of single ventricle disease, including HLHS, VSD – ventricular septal defect, CI – confidence interval.